These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19635049)

  • 21. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
    Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A
    J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prokaryotic expression, in vitro folding, and molecular pharmacological characterization of the neuropeptide Y receptor type 2.
    Schmidt P; Lindner D; Montag C; Berndt S; Beck-Sickinger AG; Rudolph R; Huster D
    Biotechnol Prog; 2009; 25(6):1732-9. PubMed ID: 19725122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internalization of neuropeptide Y Y1 and Y5 and of pancreatic polypeptide Y4 receptors is inhibited by lithium in preference to sodium and potassium ions.
    Parker MS; Parker SL; Kane JK
    Regul Pept; 2004 Apr; 118(1-2):67-74. PubMed ID: 14759559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY.
    Barden JA
    Biochem Biophys Res Commun; 1995 Oct; 215(1):264-71. PubMed ID: 7575600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability.
    Khan IU; Reppich R; Beck-Sickinger AG
    Biopolymers; 2007; 88(2):182-9. PubMed ID: 17206650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment.
    Doughty MB; Hu L
    Biopolymers; 1993 Aug; 33(8):1195-206. PubMed ID: 8364154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y receptor genes mapped in human and mouse: receptors with high affinity for pancreatic polypeptide are not clustered with receptors specific for neuropeptide Y and peptide YY.
    Lutz CM; Richards JE; Scott KL; Sinha S; Yang-Feng TL; Frankel WN; Thompson DA
    Genomics; 1997 Dec; 46(2):287-90. PubMed ID: 9417917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational analysis of neuropeptide Y segments by CD, NMR spectroscopy and restrained molecular dynamics.
    Gurrath M; Bisello A; Bottazzo K; Chung CW; Mammi S; Peggion E
    J Pept Sci; 1996; 2(3):176-93. PubMed ID: 9231326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain.
    Dumont Y; Moyse E; Fournier A; Quirion R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):99-108. PubMed ID: 15947033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neuropeptide Y monomer in solution is not folded in the pancreatic-polypeptide fold.
    Bettio A; Dinger MC; Beck-Sickinger AG
    Protein Sci; 2002 Jul; 11(7):1834-44. PubMed ID: 12070335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes.
    Schneider E; Mayer M; Ziemek R; Li L; Hutzler C; Bernhardt G; Buschauer A
    Chembiochem; 2006 Sep; 7(9):1400-9. PubMed ID: 16888730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes.
    Koglin N; Beck-Sickinger AG
    Neuropeptides; 2004 Aug; 38(4):153-61. PubMed ID: 15337368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR; Schober DA; Morin M; Berglund MM
    Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of NPY receptors in the hypothalamus.
    Fetissov SO; Kopp J; Hökfelt T
    Neuropeptides; 2004 Aug; 38(4):175-88. PubMed ID: 15337370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist induced receptor internalization of neuropeptide Y receptor subtypes depends on third intracellular loop and C-terminus.
    Böhme I; Stichel J; Walther C; Mörl K; Beck-Sickinger AG
    Cell Signal; 2008 Oct; 20(10):1740-9. PubMed ID: 18598760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-specific binding and general cross-reactivity of Y receptor agonists are correlated and should importantly depend on their acidic sectors.
    Parker MS; Sah R; Balasubramaniam A; Sallee FR; Zerbe O; Parker SL
    Peptides; 2011 Feb; 32(2):258-65. PubMed ID: 21126552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Y(4) receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa.
    Tough IR; Holliday ND; Cox HM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):20-30. PubMed ID: 16807358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modifying the conserved C-terminal tyrosine of the peptide hormone PYY3-36 to improve Y2 receptor selectivity.
    Pedersen SL; Holst B; Vrang N; Jensen KJ
    J Pept Sci; 2009 Nov; 15(11):753-9. PubMed ID: 19739125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyridone dipeptide backbone scan to elucidate structural properties of a flexible peptide segment.
    Haack M; Enck S; Seger H; Geyer A; Beck-Sickinger AG
    J Am Chem Soc; 2008 Jul; 130(26):8326-36. PubMed ID: 18529062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central Y4 receptor distribution. Radioactive ribonucleotide probe in situ hybridization with in vitro receptor autoradiography.
    Larsen PJ; Kristensen P
    Methods Mol Biol; 2000; 153():185-98. PubMed ID: 10957993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.